University of Colorado Cancer Center - Anschutz Cancer Pavilion [clinicaltrials_resource:55fe59375e2063e510f7efcc9ce2c8ae]
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer [clinicaltrials:NCT00055861]ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer [clinicaltrials:NCT00309959]Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [clinicaltrials:NCT00888173]Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye [clinicaltrials:NCT01143402]clinicaltrials:NCT01232829Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer [clinicaltrials:NCT01247571]Dasatinib and Cyclosporine in Treating Patients With Chronic Myelogenous Leukemia Refractory or Intolerant to Imatinib Mesylate [clinicaltrials:NCT01426334]Veliparib, Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [clinicaltrials:NCT01459380]clinicaltrials:NCT02278185
location [clinicaltrials_vocabulary:location]
University of Colorado Cancer Center - Anschutz Cancer Pavilion [clinicaltrials_resource:55fe59375e2063e510f7efcc9ce2c8ae]
Bio2RDF identifier
55fe59375e2063e510f7efcc9ce2c8ae
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:55fe59375e2063e510f7efcc9ce2c8ae
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:55fe59375e2063e510f7efcc9ce2c8ae
title
University of Colorado Cancer Center - Anschutz Cancer Pavilion
@en
type
label
University of Colorado Cancer ...... e59375e2063e510f7efcc9ce2c8ae]
@en